CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 74 enrolled
Drug / intervention
IV glucose insulin and potassium, GIK +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00282867
NCT00282867Phase 2Completed
CompareCT.gov

Glucose Regulation in Acute Stroke Patients (GRASP) Study

University of Virginia·interventional·Posted Jan 27, 2006·Updated Aug 21, 2009

In Brief

A Phase 2 clinical trial evaluating IV glucose insulin and potassium, GIK and standard care for Stroke and Hyperglycemia. Completed, enrolled 74 participants across 2 sites.

Detailed Summary

The purpose of this study is to assess the feasibility, safety and preliminary efficacy of the use of insulin infusions as treatment for hyperglycemic acute ischemic stroke patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Hyperglycemia
CountriesUnited States
CollaboratorsNational Institute of Neurological Disorders and Stroke (NINDS)

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2006
Enrollment StartMay 1, 2006
Primary CompletionFeb 1, 2008
Study CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 20.4 years ago

Interventions

IV glucose insulin and potassium, GIKdrug

The treatment intervention includes glucose, insulin, potassium infusion or standard therapy.

standard careother

usual care